Comparison Chart Relmada Therapeutics, Inc.
Stocks
RLMD
US75955J4022
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-09-29 EDT
|
5-day change | 1st Jan Change | ||
| 3.730 USD | -1.58% |
|
-12.03% | -22.77% |
| 09-20 | Relmada Therapeutics, Inc.(NasdaqCM:RLMD) added to S&P Global BMI Index | CI |
| 09-11 | Relmada Therapeutics Shares Rise After CEO, CFO Buy 200,000 Shares Each | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| RELMADA THERAPEUTICS, INC. | Bio Therapeutic Drugs | -1.58% | -12.03% | -22.77% | +98.40% | -85.49% | 398M |  | |  |
- Stock Market
- Stocks
- RLMD Stock
- Charts Relmada Therapeutics, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
